Back
Arcturus Therapeutics Holdings Vs. Bioventus Industry Stock Comparison
Sell
27
ARCT
Arcturus Therapeutics Holdings
Last Price:
17.18
Seasonality Move:
11.22%
Buy
74
BVS
Bioventus
Last Price:
12.27
Seasonality Move:
-3.66%
Sell
27
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?
- The current Arcturus Therapeutics Holdings [ARCT] share price is $16.93. The Score for ARCT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
74
Bioventus (BVS)
is a Buy
Is Bioventus a Buy, Sell or Hold?
- The current Bioventus [BVS] share price is $12.27. The Score for BVS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- BVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings's stock price today?
-
The Arcturus Therapeutics Holdings share price today is $16.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing selling pressure, which indicates risk of future bearish movement.
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 42.47 | Sell |
| Chaikin Money Flow: | -203765 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.06 - 19.42) | Sell |
| Bollinger Bands (100): | (18.54 - 22.88) | Sell |
BVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 54.48 | Buy |
| Chaikin Money Flow: | 269545 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.28 - 13.16) | Buy |
| Bollinger Bands (100): | (7.95 - 12.39) | Buy |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.88 | Buy |
| 20-day SMA: | 17.97 | Sell |
| 50-day SMA: | 20.09 | Sell |
| 200-day SMA: | 26.44 | Sell |
| 8-day EMA: | 17.28 | Sell |
| 20-day EMA: | 18.04 | Sell |
| 50-day EMA: | 19.44 | Sell |
| 200-day EMA: | 23.85 | Sell |
BVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.56 | Buy |
| 20-day SMA: | 11.97 | Buy |
| 50-day SMA: | 12.05 | Buy |
| 200-day SMA: | 7.76 | Buy |
| 8-day EMA: | 11.71 | Buy |
| 20-day EMA: | 11.85 | Buy |
| 50-day EMA: | 11.57 | Buy |
| 200-day EMA: | 8.59 | Buy |
Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.91 per share.
Bioventus Earnings Growth & BVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.25 per share.
Arcturus Therapeutics Holdings Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bioventus Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||